Ashima Makol

3.3k total citations
81 papers, 1.6k citations indexed

About

Ashima Makol is a scholar working on Rheumatology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ashima Makol has authored 81 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Rheumatology, 30 papers in Pathology and Forensic Medicine and 27 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ashima Makol's work include Systemic Lupus Erythematosus Research (25 papers), Systemic Sclerosis and Related Diseases (22 papers) and Vasculitis and related conditions (21 papers). Ashima Makol is often cited by papers focused on Systemic Lupus Erythematosus Research (25 papers), Systemic Sclerosis and Related Diseases (22 papers) and Vasculitis and related conditions (21 papers). Ashima Makol collaborates with scholars based in United States, Italy and United Kingdom. Ashima Makol's co-authors include Kenneth J. Warrington, Eric L. Matteson, Cynthia S. Crowson, David A. Wetter, Olayemi Sokumbi, Shreyasee Amin, Steven R. Ytterberg, Matthew J. Koster, Madhusudan Grover and Megan L. Krause and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and CHEST Journal.

In The Last Decade

Ashima Makol

76 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ashima Makol United States 25 872 664 320 251 223 81 1.6k
Thomas Daikeler Switzerland 23 669 0.8× 658 1.0× 310 1.0× 315 1.3× 201 0.9× 90 1.7k
Rosaria Talarico Italy 26 986 1.1× 516 0.8× 298 0.9× 210 0.8× 210 0.9× 108 2.0k
Varun Dhir India 19 608 0.7× 287 0.4× 232 0.7× 194 0.8× 178 0.8× 115 1.2k
F. Maurier France 20 751 0.9× 458 0.7× 262 0.8× 166 0.7× 109 0.5× 57 1.3k
Micol Frassi Italy 17 1.0k 1.2× 476 0.7× 517 1.6× 132 0.5× 131 0.6× 31 1.6k
Kenan Aksu Türkiye 28 802 0.9× 929 1.4× 390 1.2× 136 0.5× 216 1.0× 89 2.0k
Nader Khalidi Canada 27 913 1.0× 1.5k 2.2× 335 1.0× 347 1.4× 236 1.1× 95 2.0k
E. L. Matteson United States 19 967 1.1× 683 1.0× 161 0.5× 240 1.0× 170 0.8× 36 1.6k
José María Pego‐Reigosa Spain 22 959 1.1× 333 0.5× 503 1.6× 319 1.3× 142 0.6× 82 1.6k
Jörg Henes Germany 23 493 0.6× 375 0.6× 425 1.3× 384 1.5× 112 0.5× 121 1.6k

Countries citing papers authored by Ashima Makol

Since Specialization
Citations

This map shows the geographic impact of Ashima Makol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ashima Makol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ashima Makol more than expected).

Fields of papers citing papers by Ashima Makol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ashima Makol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ashima Makol. The network helps show where Ashima Makol may publish in the future.

Co-authorship network of co-authors of Ashima Makol

This figure shows the co-authorship network connecting the top 25 collaborators of Ashima Makol. A scholar is included among the top collaborators of Ashima Makol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ashima Makol. Ashima Makol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Makol, Ashima, et al.. (2023). Recent innovations in the screening and diagnosis of systemic sclerosis-associated interstitial lung disease. Expert Review of Clinical Immunology. 19(6). 613–626. 9 indexed citations
2.
Makol, Ashima, et al.. (2023). Nailfold Capillaroscopy in Rheumatic Disease. New England Journal of Medicine. 389(3). 262–262.
3.
Ravichandran, N., Parikshit Sen, Jessica Day, et al.. (2023). POS1215 FLARES AFTER COVID-19 INFECTION IN PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: RESULTS FROM THE COVAD STUDY. Annals of the Rheumatic Diseases. 82. 941–942. 2 indexed citations
4.
Davis, John M., Andrew C. Hanson, Elena Myasoedova, et al.. (2023). Time Trends in Glucocorticoid Use in Rheumatoid Arthritis During the Biologics Era: 1999-2018. Seminars in Arthritis and Rheumatism. 61. 152219–152219. 15 indexed citations
5.
Gupta, Latika, et al.. (2022). Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review. Rheumatology International. 42(9). 1629–1641. 34 indexed citations
6.
Kurmann, Reto, Edward El‐Am, Yasser Radwan, et al.. (2021). Increased Risk of Valvular Heart Disease in Systemic Sclerosis: An Underrecognized Cardiac Complication. The Journal of Rheumatology. 48(7). 1047–1052. 13 indexed citations
7.
Iwamoto, Taro, Jessica M. Dorschner, Shanmugapriya Selvaraj, et al.. (2021). High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis. The Journal of Rheumatology. 49(4). 388–397. 25 indexed citations
8.
Parkman, Henry P., Mark L. Van Natta, Ashima Makol, et al.. (2021). Prevalence and clinical correlates of antinuclear antibody in patients with gastroparesis. Neurogastroenterology & Motility. 34(5). e14270–e14270. 5 indexed citations
9.
Crowson, Cynthia S., et al.. (2020). Hospitalization Rates Are Highest in the First 5 Years of Systemic Sclerosis: Results From a Population-based Cohort (1980–2016). The Journal of Rheumatology. 48(6). 877–882. 7 indexed citations
10.
Moura, Marta Casal, María V. Irazabal, Alfonso Eirin, et al.. (2020). Efficacy of Rituximab and Plasma Exchange in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis with Severe Kidney Disease. Journal of the American Society of Nephrology. 31(11). 2688–2704. 49 indexed citations
11.
Richter, Michael, Cynthia S. Crowson, Matthew J. Koster, et al.. (2019). Rituximab Therapy for Systemic Rheumatoid Vasculitis: Indications, Outcomes, and Adverse Events. The Journal of Rheumatology. 47(4). 518–523. 12 indexed citations
12.
Radwan, Yasser, Sarah E. Berini, Floranne C. Ernste, & Ashima Makol. (2019). Proteinase 3 (PR3)-antineutrophil cytoplasmic antibody (ANCA)-associated vasculitic neuropathy in diffuse cutaneous systemic sclerosis: a rare duo. BMJ Case Reports. 12(11). e232987–e232987.
13.
Kronzer, Vanessa L., Daniel P. Larson, Cynthia S. Crowson, et al.. (2019). Occurrence and aetiology of gastrointestinal perforation in patients with vasculitis.. PubMed. 37 Suppl 117(2). 32–39. 4 indexed citations
14.
Crowson, Cynthia S., et al.. (2019). Clinical Characteristics of Biopsy-Proven IgA Vasculitis in Children and Adults: A Retrospective Cohort Study. Mayo Clinic Proceedings. 94(9). 1769–1780. 27 indexed citations
15.
Bois, John P., Heidi M. Connolly, Christopher G. Scott, et al.. (2017). Spectrum of Aortic Disease in the Giant Cell Arteritis Population. The American Journal of Cardiology. 121(4). 501–508. 26 indexed citations
16.
Alıbaz-Öner, Fatma, Matthew J. Koster, Ali Ünal, et al.. (2017). Assessment of the frequency of cardiovascular risk factors in patients with Takayasu’s arteritis. Lara D. Veeken. 56(11). 1939–1944. 31 indexed citations
17.
Makol, Ashima, et al.. (2017). RNA polymerase III–positive systemic sclerosis in a patient with circumscribed morphea. Lara D. Veeken. 56(11). 1856–1856.
18.
Koster, Matthew J., Cynthia S. Crowson, Ashima Makol, et al.. (2015). Predictors of relapse and treatment outcomes in biopsy-proven giant cell arteritis: a retrospective cohort study. Lara D. Veeken. 55(2). 347–356. 124 indexed citations
19.
Makol, Ashima, et al.. (2015). Retrospective Comparison of Open versus Endovascular Procedures for Takayasu Arteritis. The Journal of Rheumatology. 43(2). 427–432. 37 indexed citations
20.
Makol, Ashima & Michelle Petri. (2009). Pancreatitis in Systemic Lupus Erythematosus: Frequency and Associated Factors — A Review of the Hopkins Lupus Cohort. The Journal of Rheumatology. 37(2). 341–345. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Thomas Daikeler Breakdown of academic impact, for papers by Rosaria Talarico Breakdown of academic impact, for papers by Varun Dhir Breakdown of academic impact, for papers by F. Maurier Breakdown of academic impact, for papers by Micol Frassi Breakdown of academic impact, for papers by Kenan Aksu Breakdown of academic impact, for papers by Nader Khalidi Breakdown of academic impact, for papers by E. L. Matteson Breakdown of academic impact, for papers by José María Pego‐Reigosa Breakdown of academic impact, for papers by Jörg Henes
Rankless by CCL
2026